Hakimian, M. and Noori, R. 2018. The relationship between Pembrolizumab for the treatment of PD-L1 positive advanced in cell lung cancer. International Pharmacy Acta. 1, 1 (Mar. 2018), 154–154. DOI:https://doi.org/10.22037/ipa.v1i1.20499.